Medable, Inc.
Medable, Inc is a pioneering company in the field of digital health, dedicated to transforming clinical trials and patient care through innovative technology solutions. Founded with the vision of making clinical research more accessible and efficient, Medable leverages cutting-edge software to streamline the entire process from patient recruitment to data collection.
The company’s platform enables remote patient monitoring, allowing participants to engage in clinical trials from the comfort of their homes. This not only enhances patient experience but also increases retention rates, ultimately leading to more robust data collection.
Medable is committed to improving health outcomes by providing tools that empower patients and researchers alike. Their solutions are designed to facilitate real-time data sharing and collaboration among stakeholders, ensuring that everyone involved in the trial has access to the information they need.
With a strong focus on patient-centricity, Medable aims to reduce the barriers to participation in clinical research, making it easier for diverse populations to contribute to scientific advancements. The company believes that by harnessing technology, they can accelerate the development of new therapies and improve the overall efficiency of the healthcare system.
Core Values:
- Innovation: Continuously pushing the boundaries of technology to enhance clinical research.
- Accessibility: Making clinical trials more inclusive and easier for patients to participate in.
- Collaboration: Fostering partnerships with healthcare providers, researchers, and patients.
- Integrity: Upholding the highest standards of ethics and transparency in all operations.
Headquartered in the UK, Medable is strategically positioned to influence the global landscape of digital health. The company is rapidly expanding its reach, aiming to partner with pharmaceutical companies, research institutions, and healthcare organisations worldwide.
As Medable continues to grow, it remains steadfast in its mission to revolutionise the way clinical trials are conducted, ultimately leading to better health outcomes for patients everywhere.